费斯治疗 FTH
$22.05 +$2.13 (+10.69%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $25.00 +13.38%
开盘$20.16
昨收$19.92
当日区间$19.89 – $22.05
成交量539.4K
市值$569.86M
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例66.1%+0.03 个百分点，较上季度
持仓机构数56+5 ，较上季度
内部人近期交易24次买入 / 16次卖出净买入
空头持仓比例8.98% 占流通股回补天数 7.8 · 截至 15 Oct 2026
卖空成交量占比23.3%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：+$782.6K（8个净流入日，12个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有32.6%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从3.16%升至8.98%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Montanova Capital, LLC | Hedge Fund | 2026/Q3 | +1,985,554 | 7.8% |
| Avoro Capital Advisors LLC | Hedge Fund | 2026/Q3 | +1,444,039 | 5.6% |
| Baker Bros. Advisors LP | Hedge Fund | 2026/Q3 | +1,286,411 | 5.0% |
| Balyasny Asset Management L.P. | Hedge Fund | 2026/Q3 | +1,025,993 | 4.0% |
| Cormorant Asset Management, LP | Hedge Fund | 2026/Q3 | +722,020 | 4.0% |
| Fairmount Funds Management LLC | Hedge Fund | 2026/Q3 | +722,020 | 2.8% |
| RA Capital Management, L.P. | VC/PE Fund | 2026/Q3 | +722,020 | 2.8% |
| Logos Global Management, L.P. | Hedge Fund | 2026/Q3 | +692,020 | 2.8% |
| The B Group, Inc. | Hedge Fund | 2026/Q3 | +610,169 | 2.4% |
| Caligan Partners, LP | Hedge Fund | 2026/Q3 | +503,465 | 2.4% |
| Trails Edge Capital Partners, LP | Hedge Fund | 2026/Q3 | +390,335 | 2.0% |
| ADAR1 Capital Management, LLC | Hedge Fund | 2026/Q3 | +361,010 | 1.4% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +361,010 | 1.9% |
| Octagon Capital Advisors LP | Hedge Fund | 2026/Q3 | +361,010 | 1.4% |
| Boxer Capital Management, LLC | Hedge Fund | 2026/Q3 | +180,505 | 0.7% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 22 Oct 2026 | Adam Schayowitz | Director | Other Derivative Acquisition | +25,000 | $17.08 | 25,000 |
| 10 Sep 2026 | Karen Vousden | Scientific Co-Founder & Director | Other Derivative Acquisition | +25,000 | $37.44 | 25,000 |
| 10 Sep 2026 | Karen Vousden | Scientific Co-Founder & Director | Initial Statement of Beneficial | +0 | – | 42,631 |
| 21 Jul 2026 | Cambrian BioPharma, Inc. | Intent to Sell (Form 144) | -130,142 | $27.99 | – | |
| 20 Jul 2026 | Anand Parikh | CEO, President & Chair | Other Derivative Acquisition | +398,018 | $28.37 | 398,018 |
| 20 Jul 2026 | Josiah Craver | Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer | Other Derivative Acquisition | +30,824 | $28.37 | 30,824 |
| 30 Jun 2026 | Brian Stephenson | Chief Financial Officer | Open Market Acquisition | +13,634 | $24.98 | 46,688 |
| 25 Jun 2026 | Brian Stephenson | Chief Financial Officer | Open Market Acquisition | +15,641 | $27.77 | 33,054 |
| 22 Jun 2026 | Brian Stephenson | Chief Financial Officer | Open Market Acquisition | +17,413 | $25.91 | 17,413 |
| 21 Jun 2026 | Anand Parikh | CEO, President & Chair | Open Market Acquisition | +2,806 | $19.76 | 817,699 |
| 21 Jun 2026 | Anand Parikh | CEO, President & Chair | Derivative Exercise and Retained | +53,465 | $1.16 | 817,699 |
| 14 Jun 2026 | Khosla Ventures, LLC | Initial Statement of Beneficial | +0 | – | 2,632,232 | |
| 14 Jun 2026 | Stephen Hahn | Director | Derivative Exercise and Retained | +44,763 | – | 44,763 |
| 14 Jun 2026 | Anand Parikh | CEO, President & Chair | Derivative Exercise and Retained | +761,428 | – | 761,428 |
| 12 Jun 2026 | Brian Stephenson | Chief Financial Officer | Initial Statement of Beneficial | +0 | – | 166,435 |
| 11 Jun 2026 | Sona Saira Ramasastry | Director | Other Derivative Acquisition | +25,000 | $13.00 | 25,000 |
| 11 Jun 2026 | Sona Saira Ramasastry | Director | Initial Statement of Beneficial | +0 | – | 14,647 |
| 11 Jun 2026 | Stephen Hahn | Director | Other Derivative Acquisition | +25,000 | $13.00 | 25,000 |
| 11 Jun 2026 | Stephen Hahn | Director | Initial Statement of Beneficial | +0 | – | 44,763 |
| 9 Jun 2026 | Robert Holmen | Independent Director | Other Derivative Acquisition | +12,500 | $11.41 | 12,500 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 2,320,706 | 9.0% | 7.8 |
| 30 Sep 2026 | 2,067,445 | 8.0% | 3.6 |
| 15 Sep 2026 | 1,318,893 | 5.1% | 4.4 |
| 31 Aug 2026 | 1,098,324 | 4.3% | 3.7 |
| 14 Aug 2026 | 827,167 | 3.2% | 2.8 |
| 31 Jul 2026 | 815,587 | 3.2% | 2.8 |
暂无评论——快来第一个聊聊 FTH。
登录后参与讨论。